1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global Pain Management Devices Market By Product  By Application  By Region, Industry Analysis and Forecast, 2020 - 2026

Global Pain Management Devices Market By Product By Application By Region, Industry Analysis and Forecast, 2020 - 2026

  • May 2020
  • 181 pages
  • ID: 5914560
  • Format: PDF
  • KBV Research

Summary

Table of Contents

The Global Pain Management Devices Market size is expected to reach $6.3 billion by 2026, rising at a market growth of 8.5% CAGR during the forecast period. Pain management is a branch of medical science that relieves patients with chronic pain from their suffering. Acute pain has a sudden onset of action, while chronic pain persists for a longer period of time, which leads to the need for its control. Pain management devices are medical devices used to relieve different forms of pressure such as neuropathic pain, cancer pain, nociceptive pain, musculoskeletal pain among others. Stimulators for the spinal cord, transcutaneous electrical nerve stimulators, analgesic infusion pumps, and ablation devices are different types of pain management devices available on the market.

With Covid-19 infections rising globally, there is also deepening apprehension about a shortage of essential life-saving devices and other essential medical supplies to prevent the spread of this pandemic and provide optimum care to those infected. Additionally, for COVID-19 patients, who may require critical care, ventilators act as a vital treatment preference until a pharmacological treatment is developed. In addition, a wide range of test-kits (antibody tests, self-administered, and others) involves a fast acceleration in the manufacturing phase.

Growth in the global market for pain management devices is driven by the increase in geriatric population, a rise in chronic pain pervasiveness, growing awareness of people’s awareness of pain management devices, improved investment in R&D to develop innovative products and the launch of new products. Additionally, growing demand for pain management devices in emerging countries and increasing the use of pain management devices for chronic pain management are other factors contributing to market growth. In addition, the untapped potential offered by developing economies is presenting lucrative market expansion opportunities over the forecast period. Nevertheless, reactions to hypersensitivity and postoperative infections caused by the use of these devices restrict their adoption, which hampers the market growth.

Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The major strategies followed by the market participants are Partnerships and Acquisition. Based on the Analysis presented in the Cardinal matrix, Johnson and Johnson and Pfizer, Inc. are the forerunners in the Pain Management Devices Market. Companies such as Boston Scientific Corporation, Medtronic PLC, Colfax Corporation, Stryker Corporation, Kimberly-Clark Corporation, and Abbott Laboratories, Baxter International, Inc., and B. Braun Melsungen AG are some of the key innovators in the market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)

Recent strategies deployed in Pain Management Devices Market

Partnerships, Collaborations, and Agreements:

May-2020: Medtronic collaborated with UW following which the company has accelerated research into deep brain stimulation treatment for essential tremor, Parkinson’s disease, and other neurological disorders.

May-2019: Abbott came into partnership with the US National Institutes of Health (NIH). The partnership was aimed at developing unique insights and driving the application of neurostimulation therapies. The partnership would provide the latter company’s neuroscience research initiative BRAIN access to Abbott’s neuromodulation technologies.

Approvals:

Jan-2020: Abbott Laboratories got approval from the US Food and Drug Administration (FDA) for its Infinity Deep Brain Stimulation (DBS) system. This system would be used in the treatment of Parkinson’s disease. The system would enable targeting a specific area of the brain known as the internal globus pallidus (GPi) for improving the symptoms of Parkinson’s disease not controlled by medication.

Jan-2020: Medtronic secured a CE Mark for its Percept PC neurostimulator. It is the only deep brain stimulation (DBS) system launched in the EU with BrainSense technology, which senses and records brain signals while delivering DBS therapy to people with neurological disorders such as Parkinson’s disease.

Sep-2019: Abbott announced that the U.S. Food and Drug Administration (FDA) approved its Proclaim XR recharge-free neurostimulation system for people living with chronic pain. The Proclaim XR platform provides a low dose of Abbott’s proprietary BurstDR stimulation waveform, which was created based on scientific insights from doctors and researchers to mimic natural patterns found in the brain. It works by using low doses of mild electrical pulses to change pain signals as they travel from the spinal cord to the brain.

Acquisition and Mergers:

Jan-2020: Medtronic took over Stimgenics, a startup company that has developed a novel spinal cord stimulation waveform. This acquisition enabled the company to expand its business in the SCS Market.

Jun-2019: Boston Scientific acquired Vertiflex, a healthcare company. Through this acquisition, Vertiflex’s spinal cord stimulation and radiofrequency ablation have been added to Boston Scientific’s product portfolio.

Oct-2017: Stryker Corporation took over VEXIM, a medical device company specializing in the minimally invasive treatment of vertebral fractures. Through this acquisition, Stryker enabled the latter company to become a global leader in trauma and expanded its geographical foothold.

Jun-2017: DePuy Synthes Products, Inc., part of the Johnson & Johnson Medical Devices Companies acquired Innovative Surgical Solutions, LLC, doing business as Sentio, LLC, a company that markets innovative nerve localization technology for spine surgery. The acquisition strengthened its spine portfolio in decompression procedures as well as lateral surgery and developed a platform for future innovation in minimally invasive surgery.

Jul-2016: Boston took over Cosman Medical following which Cosman operates under the Boston Scientific Neuromodulation business. Following the acquisition, the company aimed to offer a wide range of spinal cord stimulator (SCS) systems to the patients suffering from chronic pain.

Product Launches and Product Expansions:

Jan-2019: Boston Scientific introduced the Vercise Primary Cell (PC) and Vercise Gevia Deep Brain Stimulation (DBS) Systems. The systems feature the Vercise Cartesia Directional Lead. The systems have the technology that enables the physicians in controlling the range, shape, position, and direction of electrical stimulation to treat the symptoms of Parkinson’s disease (PD) through highly-personalized therapy.

Jan-2019: Boston launched WaveWriter Spinal Cord Stimulator (SCS) System in Europe for providing the treatment of chronic pain to people in Europe.

Scope of the Study

Market Segmentation:

By Product

• Neuromodulation & Neurostimulation Devices

• Analgesic Infusion Pumps and

• Ablation Devices

By Application

• Neuropathic Pain

• Musculoskeletal Pain

• Cancer Pain

• Facial & Migraine Pain and

• Other Applications

By Geography

• North America

o US

o Canada

o Mexico

o Rest of North America

• Europe

o Germany

o UK

o France

o Russia

o Spain

o Italy

o Rest of Europe

• Asia Pacific

o China

o Japan

o India

o South Korea

o Singapore

o Malaysia

o Rest of Asia Pacific

• LAMEA

o Brazil

o Argentina

o UAE

o Saudi Arabia

o South Africa

o Nigeria

o Rest of LAMEA

Companies Profiled

• Abbott Laboratories

• B. Braun Melsungen AG

• Baxter International, Inc.

• Pfizer, Inc.

• Boston Scientific Corporation

• Johnson and Johnson

• Medtronic PLC

• Kimberly-Clark Corporation

• Stryker Corporation

• Colfax Corporation (DJO Global, Inc.)

Unique Offerings

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.

ref:plp2020

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on